Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VD's Model Portfolio & Discussion Thread -- Ignore unavailable to you. Want to Upgrade?

To: Gary L. Kepler who wrote (5536)	9/1/1998 12:37:00 AM
From: Rocketman	Respond to of 9719

Sounds impressive. I don't see an impact on INCY as they don't deal in this aspect of science. Their Synteni stuff uses microarray plates with 10,000 spots of DNA on each of them for genetic screening. This system uses 96 well plates, which I assume uses a liquid in them. However, with my limited knowledge of the subject, it seems to me that it could have more of an impact on ABSC although I am not that up to speed on their system. Get used to these kinds of things ramping up in quantum leaps. Biology is moving from the pipette in a research assistant's hand to technicians running high speed robots. I'm sure others out there have a more relevant understanding of the companies that will be competing with Tropix. Rman